MEDIA & PRESS
Our press kit containing the most detailed and updated information is available for download. Also available is a selection of documents and articles on the history, development and activities related to the PSE of Biasca industrial area.
Safeguarding the Past, Building the Future – Article in the 2026/3 issue of Rivista Patriziale ALPA
An article highlighting the role of the Patriziato di Biasca and its forward-looking decision to make its land available to support the economic development of the region, creating opportunities for businesses, employment and new prospects for the future. Read the full article.
HAS Healthcare Announces Strategic Investment Plan to Strengthen Its Presence in Biasca
Biasca, January 13, 2026. HAS Healthcare Announces Strategic Investment Plan to Strengthen Its Presence in Biasca HAS Healthcare Advanced Synthesis SA Group, formed through the integration of HAS and Cerbios, has unveiled a five-year strategic investment plan exceeding CHF 100 million to strengthen its leadership in CDMO services and ADC (Antibody-Drug Conjugates) manufacturing. The investments [...]
New Area Manager – Sabrina Tilli
The Regional Authority for the Development of the Bellinzona Area and Valleys is pleased to announce the appointment of Sabrina Tilli as the new Area Manager. She succeeds Stefano Melera, who is approaching retirement after many years of valuable commitment in support of the Region’s economic development. With a solid background in business management and [...]
HAS Healthcare Advanced Synthesis SA completes the acquisition of Cerbios-Pharma SA
Biasca, Switzerland, May 7, 2025 – HAS Healthcare Advanced Synthesis SA (“HAS”), a leading international developer and producer of active pharmaceutical ingredients (APIs), high-potency active pharmaceutical ingredients (HPAPIs), and anticancer compounds, is pleased to announce today the successful completion of its previously announced acquisition of Cerbios-Pharma SA (Cerbios), a globally recognised manufacturer of chemical and biological [...]
HAS Healthcare Advanced Synthesis SA acquires Cerbios-Pharma SA
Biasca, Switzerland, March 31, 2025 – HAS Healthcare Advanced Synthesis SA (“HAS”), a leading international developer and producer of active pharmaceutical ingredients (APIs), high-potency active pharmaceutical ingredients (HPAPIs), and anticancer compounds, today announces the planned acquisition of Cerbios-Pharma SA (Cerbios), a globally recognised manufacturer of chemical and biological APIs, including in the fast-growing area of antibody [...]